Cargando…
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
That certain cell types in the central nervous system are more likely to undergo neurodegeneration in Parkinson’s disease is a widely appreciated but poorly understood phenomenon. Many vulnerable subpopulations, including dopamine neurons in the substantia nigra pars compacta, have a shared phenotyp...
Autores principales: | Ge, Preston, Dawson, Valina L., Dawson, Ted M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071653/ https://www.ncbi.nlm.nih.gov/pubmed/32169097 http://dx.doi.org/10.1186/s13024-020-00367-7 |
Ejemplares similares
-
PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
por: Pirooznia, Sheila K., et al.
Publicado: (2020) -
The cell biology of Parkinson’s disease
por: Panicker, Nikhil, et al.
Publicado: (2021) -
Mitochondrial quality control beyond PINK1/Parkin
por: von Stockum, Sophia, et al.
Publicado: (2018) -
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control
por: Zhuang, Na, et al.
Publicado: (2016) -
The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010)